Skin: Difference between revisions

Jump to navigation Jump to search
Mikael Häggström (talk | contribs)
Mikael Häggström (talk | contribs)
Noinclude
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
{{Top
<noinclude>{{Top
|author1=[[User:Mikael Häggström|Mikael Häggström]]
|author1=[[User:Mikael Häggström|Mikael Häggström]]
|author2=
|author2=
Line 7: Line 7:
{{Fixation - general notes}}
{{Fixation - general notes}}
*Suspected '''immunologic disease''':<ref name="ChhabraMinz2012">Page 678 in: {{cite journal|last1=Chhabra|first1=Seema|last2=Minz|first2=RanjanaWalker|last3=Saikia|first3=Biman|title=Immunofluorescence in dermatology|journal=Indian Journal of Dermatology, Venereology, and Leprology|volume=78|issue=6|year=2012|pages=677|issn=0378-6323|doi=10.4103/0378-6323.102355|url=https://pdfs.semanticscholar.org/23d0/148dbe342a93e0bc65a6a2e31040a89113ba.pdf}}</ref> Fixation for immunofluorescence, with for example [[Michel's solution]].<ref name=kvast>{{cite web|url=http://www.svfp.se/foreningar/uploads/L15178/kvast/hud/Handlaggning%20av%20hudprover%20%20provtagningsanvisningar%20utskarningsprinciper%20och%20snittning%2020150325.pdf|title=Handläggning av hudprover – provtagningsanvisningar, utskärningsprinciper och snittning (Handling of skin samples - Instructions for sampling, cutting and incision|author=Katarzyna Lundmark, Krynitz, Ismini Vassilaki, Lena Mölne, Annika Ternesten Bratel|accessdate=2019-09-09|website=KVAST (Swedish Society of Pathology)}}</ref> ''For details, see [[immunofluorescense of skin tissues]]''
*Suspected '''immunologic disease''':<ref name="ChhabraMinz2012">Page 678 in: {{cite journal|last1=Chhabra|first1=Seema|last2=Minz|first2=RanjanaWalker|last3=Saikia|first3=Biman|title=Immunofluorescence in dermatology|journal=Indian Journal of Dermatology, Venereology, and Leprology|volume=78|issue=6|year=2012|pages=677|issn=0378-6323|doi=10.4103/0378-6323.102355|url=https://pdfs.semanticscholar.org/23d0/148dbe342a93e0bc65a6a2e31040a89113ba.pdf}}</ref> Fixation for immunofluorescence, with for example [[Michel's solution]].<ref name=kvast>{{cite web|url=http://www.svfp.se/foreningar/uploads/L15178/kvast/hud/Handlaggning%20av%20hudprover%20%20provtagningsanvisningar%20utskarningsprinciper%20och%20snittning%2020150325.pdf|title=Handläggning av hudprover – provtagningsanvisningar, utskärningsprinciper och snittning (Handling of skin samples - Instructions for sampling, cutting and incision|author=Katarzyna Lundmark, Krynitz, Ismini Vassilaki, Lena Mölne, Annika Ternesten Bratel|accessdate=2019-09-09|website=KVAST (Swedish Society of Pathology)}}</ref> ''For details, see [[immunofluorescense of skin tissues]]''
<noinclude>
 
==Presentations==
==Presentations==
<gallery>
<gallery>
Line 30: Line 30:
*Is it a '''[[suspected malignant skin excisions|suspected malignant skin excision]]'''? If not:
*Is it a '''[[suspected malignant skin excisions|suspected malignant skin excision]]'''? If not:
*If primarily inflammatory, evaluate as '''[[dermatitis]]'''. If none of these, evaluate as:
*If primarily inflammatory, evaluate as '''[[dermatitis]]'''. If none of these, evaluate as:
*'''[[Benign non-inflammatory skin conditions]]'''
*'''[[Benign non-inflammatory skin conditions]]''', including '''[[skin cyst]]s'''


In '''intraoperative''' consultations by frozen section, it is generally sufficient to report clear margins if present, and specification of the type of tumor can be deferred to permanent sections.
In '''intraoperative''' consultations by frozen section, it is generally sufficient to report clear margins if present, and specification of the type of tumor can be deferred to permanent sections.
Line 42: Line 42:
:*Radicality/Least distance to a margin
:*Radicality/Least distance to a margin
:*Perineural or vascular invasion if present
:*Perineural or vascular invasion if present
{{Bottom}}
<noinclude>{{Bottom}}</noinclude>